Please see below for a selection of interesting articles on pediatric CML in peer-reviewed journals. Latest publications include:

• A phase 2 study of nilotinib in pediatric patients with CML: Long-term update on growth retardation and safety
  Hijiya N et al. Blood Adv, July 2021 open access publication
• Adolescents experienced more treatment failure than children with CML receiving imatinib as frontline therapy: a retrospective multicentre study
  Dou X et al. Ann Hematol, June 2021 (epub ahead of print)
• Sudden blast phase in paediatric chronic myeloid leukemia-chronic phase with abnormal blasts detected by flow cytometry at diagnosis. Can it be considered a warning sign?
  Vijayasekharan K et al. Cytometry B Clin Cytom, May 2021
• Tyrosine kinase inhibitors and beyond for chronic myeloid leukemia in children
  Phillips LN and Hijiya N. Paediatr Drug, April 2021 (epub ahead of print)
• Paediatric chronic myeloid leukemia presenting in de novo or secondary blast phase – a comparison of clinical and genetic characteristics
  Sembill S et al. Br J Haematol, March 2021 (epub ahead of print) – open access publication
  
• Chronic myelogenous leukemia in childhood
  Smith SM et al. Curr Oncol Rep, March 2021
• Definition, epidemiology, pathophysiology, and essential criteria for diagnosis of pediatric chronic myeloid leukemia
  Suttorp M et al. Cancers(Basel), February 2021 – open access publication

Search here for more publications on pediatric CML